114 related articles for article (PubMed ID: 38086436)
1. Rev-erbα attenuates diabetic myocardial injury through regulation of ferroptosis.
Tian H; Huang Q; Cheng J; Xiong Y; Xia Z
Cell Signal; 2024 Feb; 114():111006. PubMed ID: 38086436
[TBL] [Abstract][Full Text] [Related]
2. Inhibiting Rev-erbα-mediated ferroptosis alleviates susceptibility to myocardial ischemia-reperfusion injury in type 2 diabetes.
Huang Q; Tian H; Tian L; Zhao X; Li L; Zhang Y; Qiu Z; Lei S; Xia Z
Free Radic Biol Med; 2023 Nov; 209(Pt 1):135-150. PubMed ID: 37805047
[TBL] [Abstract][Full Text] [Related]
3. 6-Gingerol Alleviates Ferroptosis and Inflammation of Diabetic Cardiomyopathy via the Nrf2/HO-1 Pathway.
Wu S; Zhu J; Wu G; Hu Z; Ying P; Bao Z; Ding Z; Tan X
Oxid Med Cell Longev; 2022; 2022():3027514. PubMed ID: 36624878
[TBL] [Abstract][Full Text] [Related]
4. Roles of HDAC3-orchestrated circadian clock gene oscillations in diabetic rats following myocardial ischaemia/reperfusion injury.
Qiu Z; Ming H; Lei S; Zhou B; Zhao B; Yu Y; Xue R; Xia Z
Cell Death Dis; 2021 Jan; 12(1):43. PubMed ID: 33414413
[TBL] [Abstract][Full Text] [Related]
5. Luteolin protects against diabetic cardiomyopathy by inhibiting NF-κB-mediated inflammation and activating the Nrf2-mediated antioxidant responses.
Li L; Luo W; Qian Y; Zhu W; Qian J; Li J; Jin Y; Xu X; Liang G
Phytomedicine; 2019 Jun; 59():152774. PubMed ID: 31009852
[TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine ameliorates diabetic cardiomyopathy by inhibiting ferroptosis through the Nrf2/GPX4 pathway.
Li F; Hu Z; Huang Y; Zhan H
J Cardiothorac Surg; 2023 Jul; 18(1):223. PubMed ID: 37430319
[TBL] [Abstract][Full Text] [Related]
7. SIRT6‑specific inhibitor OSS‑128167 exacerbates diabetic cardiomyopathy by aggravating inflammation and oxidative stress.
Huang Y; Zhang J; Xu D; Peng Y; Jin Y; Zhang L
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760202
[TBL] [Abstract][Full Text] [Related]
8. Activation of NRF2/FPN1 pathway attenuates myocardial ischemia-reperfusion injury in diabetic rats by regulating iron homeostasis and ferroptosis.
Tian H; Xiong Y; Zhang Y; Leng Y; Tao J; Li L; Qiu Z; Xia Z
Cell Stress Chaperones; 2021 Mar; 27(2):149-164. PubMed ID: 35124772
[TBL] [Abstract][Full Text] [Related]
9. Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic cardiomyopathy in rats.
Luo J; Yan D; Li S; Liu S; Zeng F; Cheung CW; Liu H; Irwin MG; Huang H; Xia Z
J Cell Mol Med; 2020 Jan; 24(2):1760-1773. PubMed ID: 31856386
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of sulforaphane on type 2 diabetes-induced cardiomyopathy via AMPK-mediated activation of lipid metabolic pathways and NRF2 function.
Sun Y; Zhou S; Guo H; Zhang J; Ma T; Zheng Y; Zhang Z; Cai L
Metabolism; 2020 Jan; 102():154002. PubMed ID: 31706979
[TBL] [Abstract][Full Text] [Related]
11. Kaempferol attenuates hyperglycemia-induced cardiac injuries by inhibiting inflammatory responses and oxidative stress.
Chen X; Qian J; Wang L; Li J; Zhao Y; Han J; Khan Z; Chen X; Wang J; Liang G
Endocrine; 2018 Apr; 60(1):83-94. PubMed ID: 29392616
[TBL] [Abstract][Full Text] [Related]
12. Piceatannol alleviates inflammation and oxidative stress via modulation of the Nrf2/HO-1 and NF-κB pathways in diabetic cardiomyopathy.
Li H; Shi Y; Wang X; Li P; Zhang S; Wu T; Yan Y; Zhan Y; Ren Y; Rong X; Xia T; Chu M; Wu R
Chem Biol Interact; 2019 Sep; 310():108754. PubMed ID: 31323227
[TBL] [Abstract][Full Text] [Related]
13. Isoliquiritigenin attenuates diabetic cardiomyopathy via inhibition of hyperglycemia-induced inflammatory response and oxidative stress.
Gu X; Shi Y; Chen X; Sun Z; Luo W; Hu X; Jin G; You S; Qian Y; Wu W; Liang G; Wu G; Chen Z; Chen X
Phytomedicine; 2020 Nov; 78():153319. PubMed ID: 32950951
[TBL] [Abstract][Full Text] [Related]
14. Astragaloside IV attenuates myocardial dysfunction in diabetic cardiomyopathy rats through downregulation of CD36-mediated ferroptosis.
Li X; Li Z; Dong X; Wu Y; Li B; Kuang B; Chen G; Zhang L
Phytother Res; 2023 Jul; 37(7):3042-3056. PubMed ID: 36882189
[TBL] [Abstract][Full Text] [Related]
15. Metallothionein Is Downstream of Nrf2 and Partially Mediates Sulforaphane Prevention of Diabetic Cardiomyopathy.
Gu J; Cheng Y; Wu H; Kong L; Wang S; Xu Z; Zhang Z; Tan Y; Keller BB; Zhou H; Wang Y; Xu Z; Cai L
Diabetes; 2017 Feb; 66(2):529-542. PubMed ID: 27903744
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart.
Yang H; Feng A; Lin S; Yu L; Lin X; Yan X; Lu X; Zhang C
Cell Death Dis; 2018 Feb; 9(2):227. PubMed ID: 29445083
[TBL] [Abstract][Full Text] [Related]
17. Canagliflozin mitigates ferroptosis and improves myocardial oxidative stress in mice with diabetic cardiomyopathy.
Du S; Shi H; Xiong L; Wang P; Shi Y
Front Endocrinol (Lausanne); 2022; 13():1011669. PubMed ID: 36313744
[TBL] [Abstract][Full Text] [Related]
18. An Aza resveratrol-chalcone derivative 6b protects mice against diabetic cardiomyopathy by alleviating inflammation and oxidative stress.
You S; Qian J; Sun C; Zhang H; Ye S; Chen T; Xu Z; Wang J; Huang W; Liang G
J Cell Mol Med; 2018 Mar; 22(3):1931-1943. PubMed ID: 29327811
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of NF-κB by USP24 aggravates ferroptosis in diabetic cardiomyopathy.
Wu S; Zhou Y; Liang J; Ying P; Situ Q; Tan X; Zhu J
Free Radic Biol Med; 2024 Jan; 210():352-366. PubMed ID: 38056575
[TBL] [Abstract][Full Text] [Related]
20. Cardioprotective effects of asiaticoside against diabetic cardiomyopathy: Activation of the AMPK/Nrf2 pathway.
Xu C; Xia L; Xu D; Liu Y; Jin P; Zhai M; Mao Y; Wang Y; Wen A; Yang J; Yang L
J Cell Mol Med; 2024 Jan; 28(2):e18055. PubMed ID: 38113341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
